SCHEMBL6963697

SCHEMBL6963697

CC(C)CC(SCc1ccccc1)c1c(O)cc(-c2ccc(OCc3cccnc3)c(F)c2)oc1=O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERN1 O75460 1/20 0.35
PDCD1 Q15116 1/20 0.35
CD274 Q9NZQ7 1/20 0.35
LRRK2 Q5S007 4/20 0.34
CYP11B1 P15538 4/20 0.34
CYP11B2 P19099 4/20 0.34
CTSA P10619 1/20 0.34
CYP19A1 P11511 3/20 0.33
PDE3B Q13370 1/20 0.33
PDE3A Q14432 1/20 0.33
MAOB P27338 2/20 0.33
IKBKB O14920 1/20 0.33
KLK8 O60259 1/20 0.33
F2 P00734 1/20 0.33
KLKB1 P03952 1/20 0.33
KLK1 P06870 1/20 0.33
KLK14 Q9P0G3 1/20 0.33
KLK5 Q9Y337 1/20 0.33
ST14 Q9Y5Y6 1/20 0.33
PRKDC P78527 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8534635 0.85 ERN1 (0.37) ERN1PDCD1CD274LRRK2CYP11B1
SCHEMBL9039058 0.79 ERN1 (0.34) ERN1LRRK2CTSACYP19A1PDE3B
SCHEMBL6954004 0.78 SMN1; SMN2 (0.41) CYP19A1
SCHEMBL6953958 0.75 ABCB1 (0.38) MAOBPRKDC
SCHEMBL6965574 0.74 ALDH1A1 (0.42)
SCHEMBL6964221 0.70 HTR1A (0.41) LRRK2CYP11B1CYP11B2CYP19A1PDE3B
SCHEMBL7409285 0.70 ABCB1 (0.39)
SCHEMBL7376620 0.70 ADAMTS4 (0.42)
SCHEMBL6957968 0.70 PDE4A (0.36) PDCD1CD274LRRK2CYP11B1CYP11B2
SCHEMBL7370949 0.68 ADAMTS4 (0.40) PRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed
US-6005103-A TREATMENT OF BACTERIAL AND VIRAL INFECTIONS AND DISEASES, INCLUDING AIDS WARNER-LAMBERT COMPANY (US) 1999-12-21 US disclosed
EP-0729466-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
EP-0729465-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1996-09-04 EP disclosed
WO-1995014013-A1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed
WO-1995014014-A2 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE, DAVIS & COMPANY (US) 1995-05-26 WO disclosed